Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001689375-24-000038
Filing Date
2024-06-14
Accepted
2024-06-14 16:39:26
Documents
1
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1718397557.html 4  
1 FORM 4 wk-form4_1718397557.xml 4 3900
  Complete submission text file 0001689375-24-000038.txt   5478
Mailing Address C/O 5AM VENTURES 501 2ND STREET, SUITE 350 SAN FRANCISCO CA 94107
Business Address
PARMAR KUSH (Reporting) CIK: 0001664281 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40969 | Film No.: 241045465

Mailing Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210
Business Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Issuer) CIK: 0001689375 (see all company filings)

EIN.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)